A detailed history of Bank Of America Corp transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 111,032 shares of KYMR stock, worth $4.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,032
Previous 151,191 26.56%
Holding current value
$4.66 Million
Previous $4.51 Million 16.44%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.16 - $52.4 $1.21 Million - $2.1 Million
-40,159 Reduced 26.56%
111,032 $5.26 Million
Q2 2024

Aug 14, 2024

SELL
$29.85 - $39.42 $331,335 - $437,562
-11,100 Reduced 6.84%
151,191 $4.51 Million
Q1 2024

May 15, 2024

BUY
$22.9 - $43.57 $3.03 Million - $5.76 Million
132,293 Added 441.01%
162,291 $6.52 Million
Q4 2023

Feb 14, 2024

SELL
$10.97 - $26.84 $1.21 Million - $2.95 Million
-110,026 Reduced 78.58%
29,998 $763,000
Q2 2023

Aug 14, 2023

SELL
$22.4 - $34.92 $3.06 Million - $4.78 Million
-136,764 Reduced 49.41%
140,024 $3.22 Million
Q1 2023

May 12, 2023

BUY
$24.84 - $38.75 $1.74 Million - $2.71 Million
69,905 Added 33.79%
276,788 $8.2 Million
Q4 2022

Feb 10, 2023

BUY
$19.57 - $30.92 $1.59 Million - $2.51 Million
81,307 Added 64.75%
206,883 $5.16 Million
Q3 2022

Nov 14, 2022

BUY
$20.91 - $34.27 $135,141 - $221,487
6,463 Added 5.43%
125,576 $2.73 Million
Q2 2022

Aug 12, 2022

SELL
$14.13 - $42.55 $143,066 - $430,818
-10,125 Reduced 7.83%
119,113 $2.35 Million
Q1 2022

May 16, 2022

BUY
$35.3 - $64.68 $2.01 Million - $3.67 Million
56,818 Added 78.46%
129,238 $5.47 Million
Q4 2021

Feb 08, 2022

BUY
$49.91 - $65.56 $1.82 Million - $2.39 Million
36,414 Added 101.13%
72,420 $4.6 Million
Q3 2021

Nov 15, 2021

BUY
$47.8 - $66.66 $1.32 Million - $1.84 Million
27,654 Added 331.11%
36,006 $2.12 Million
Q2 2021

Sep 13, 2021

BUY
$31.08 - $51.95 $259,580 - $433,886
8,352 New
8,352 $405,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.3B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.